Publications by authors named "Mark Mina"

Claim this Profile
P
Phase 2 study of futibatinib in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplifications.
Taroh Satoh, Philippe Barthélémy, Lucia Nogova, Kazunori Honda, Hidekazu Hirano, Mark Mina

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Cytochrome P450 3A and P-glycoprotein Drug-Drug Interaction Potential of Futibatinib.
Ikuo Yamamiya, Allen Hunt, Toru Takenaka, Daryl Sonnichsen, Mark Mina

Clin Pharmacol Drug Dev· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Futibatinib on Cardiac Repolarization: Results of a Randomized, Controlled, Double-Blind, QT/QTc, Phase 1 Study in Healthy Subjects.
Ikuo Yamamiya, Robert Lester, Daryl Sonnichsen, Mark Mina, Yaohua He

Clin Pharmacol Drug Dev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis